Company: ALM
Filing Date: 2025-07-11
Form Type: F-10/A
Source: 0001641172-25-018741
Chunk: 212

Company: Almonty Industries Inc.
Filing Date: 2025-07-11
Form: F-10/A
Chunk 212
---
Indemnification

We have also agreed
to indemnify the Underwriters against certain liabilities, including under the U.S. Securities Act, the Exchange Act or other
federal or state law or regulation or Canadian law, at common law or otherwise, and to contribute to payments that the Underwriters
may be required to make in respect of those liabilities.

Option to Purchase
Additional Common Shares

In addition, the Company
has granted the Underwriters the Over-Allotment Option, which is exercisable in whole or in part for a period of 30 days from and including
the Closing and pursuant to which the Underwriters may purchase Additional Shares, being up to an additional 15% the Offering, on the
same terms as set forth above to cover over-allotments, if any, and for market stabilization purposes. This prospectus qualifies the
grant of the Over-Allotment Option and the issuance of Additional Shares on the exercise of the Over-Allotment Option. A purchaser who
acquires Additional Shares forming part of the Underwriters’ over-allocation position acquires those Additional Shares under this
prospectus.

Commission

In consideration for
the services provided by the Underwriters, the Company has agreed to pay to the Underwriters’ Fee equal to 6.50% of the gross proceeds
realized on the proceeds of the Offering (including on any exercise of the Over-Allotment Option); provided, however, that a reduced
fee of 4.50% shall be paid in respect of that portion of gross proceeds attributable to investors who participate in the Offering that
were introduced by the Company or its principals as friends and family (such list of investors to be provided in writing by the Company
to the Lead Underwriter from time to time prior to the date of this prospectus). Notwithstanding the foregoing, purchasers who acquire
Common Shares through the list will have the same rights and remedies against the Company and the Underwriters, as the case may be, as
purchasers who acquired Common Shares through the Underwriters.

The Company has agreed to reimburse the Underwriters
for reasonable fees and expenses and out-of-pocket expenses incurred in connection with the Offering, and, subject to a maximum aggregate
amount of US$450,000, for the fees and disbursements of the Underwriters’ legal counsel. In addition, the Company may (in its sole
discretion) award up to an additional 0.50% of the gross proceeds of this Offering